New Treatment Found To Reduce Hyperkalemia Risk in Those With CKD and Type 2 Diabetes

A recent clinical trial called CREDENCE has uncovered that canagliflozin, a sodium-glucose cotransporter 2 (SGLT2), can reduce hyperkalemia risk in chronic kidney disease (CKD) and type 2 diabetes patients who…

Continue Reading New Treatment Found To Reduce Hyperkalemia Risk in Those With CKD and Type 2 Diabetes
Patients with Chronic Kidney Disease and Hyperkalemia Associated with Major Adverse Cardiovascular Events
Photo by Robina Weermeijer on Unsplash

Patients with Chronic Kidney Disease and Hyperkalemia Associated with Major Adverse Cardiovascular Events

According to a recent article, a study shows patients with nondialysis-dependent chronic kidney disease and transient or chronic hyperkalemia, correspond with major adverse cardiovascular events (MACE) and even death. Chronic…

Continue Reading Patients with Chronic Kidney Disease and Hyperkalemia Associated with Major Adverse Cardiovascular Events
Doctors Explain How To Assess Chronic Kidney Disease Staging for Patients
source: pixabay.com

Doctors Explain How To Assess Chronic Kidney Disease Staging for Patients

Dr. Bakris, Dr. Agarwal, Dr. Wright, and Dr. Minkoff have recently come together to discuss how they assess kidney function and ultimately diagnose chronic kidney disease (CKD). Assessing Disease Severity…

Continue Reading Doctors Explain How To Assess Chronic Kidney Disease Staging for Patients
Study Finds Metabolic Syndrome is Not Associated with Death for Chronic Kidney Disease Patients
source: pixabay.com

Study Finds Metabolic Syndrome is Not Associated with Death for Chronic Kidney Disease Patients

A recent study has investigated the association between cardiovascular disease risk factors and fat distribution. Researchers used linear regression analyses and adjusted for insulin sensitivity and other factors. Previous research…

Continue Reading Study Finds Metabolic Syndrome is Not Associated with Death for Chronic Kidney Disease Patients
FDA Rejects CKD Drug Tenapanor
Photo by Paweł Czerwiński on Unsplash

FDA Rejects CKD Drug Tenapanor

Despite drug developers' best efforts, the path to approval is not always easy. Ask biotechnology company Ardelyx, whose potential treatment option tenapanor was recently rejected by the FDA. According to…

Continue Reading FDA Rejects CKD Drug Tenapanor
Farxiga Now FDA-Approved to Treat CKD
https://unsplash.com/photos/_jbClosDsD4

Farxiga Now FDA-Approved to Treat CKD

According to BioSpace, Farxiga (dapagliflozin), a treatment for patients with chronic kidney disease (CKD) and a risk of progression, recently became FDA-approved. Developed by AstraZeneca, the therapy is specifically designed…

Continue Reading Farxiga Now FDA-Approved to Treat CKD
Clinical Data on AZP-3601 for Hypoparathyroidism Presented at ENDO 2021
rawpixel / Pixabay

Clinical Data on AZP-3601 for Hypoparathyroidism Presented at ENDO 2021

  At the Endocrine Society's Annual Meeting, or ENDO 2021, Amolyt Pharma ("Amolyt") shared positive clinical data from a Phase 1 clinical trial evaluating AZP-3601 for patients with hypoparathyroidism. Although…

Continue Reading Clinical Data on AZP-3601 for Hypoparathyroidism Presented at ENDO 2021
Four New Rare Disease Studies Receive $19 Million in Funding
source: pixabay.com

Four New Rare Disease Studies Receive $19 Million in Funding

The Patient-Centered Outcomes Research Institute (PCORI) has announced that it will be contributing funding for four new studies focused on four different rare diseases. The funding will top out at…

Continue Reading Four New Rare Disease Studies Receive $19 Million in Funding
Chronic Kidney Disease Treatment is More Widely Available in Tennessee and Alabama
qimono / Pixabay

Chronic Kidney Disease Treatment is More Widely Available in Tennessee and Alabama

Monogram Health has recently announced that they will be expanding their collaboration with Humana Inc. to provide greater access to chronic kidney disease and end-stage renal disease treatment. They will…

Continue Reading Chronic Kidney Disease Treatment is More Widely Available in Tennessee and Alabama
Researchers Illuminate Link Between Type 2 Diabetes, Chronic Kidney Disease, and Left Ventricular Strain
source: pixabay.com

Researchers Illuminate Link Between Type 2 Diabetes, Chronic Kidney Disease, and Left Ventricular Strain

A study has recently highlighted the fact that patients who have type 2 diabetes are more susceptible to chronic kidney disease (CKD), and as a result, cardiac issues. This study…

Continue Reading Researchers Illuminate Link Between Type 2 Diabetes, Chronic Kidney Disease, and Left Ventricular Strain
Unmet Needs in the Treatment of Certain Glomerular Diseases
source: pixabay.com

Unmet Needs in the Treatment of Certain Glomerular Diseases

by Lauren Taylor from In The Cloud Copy Nephrologists worldwide have shown that there is a huge unmet need when it comes to the treatment of various glomerular diseases, in…

Continue Reading Unmet Needs in the Treatment of Certain Glomerular Diseases